{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:04:32Z","timestamp":1771567472672,"version":"3.50.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"\n Introduction<\/jats:title>\n Myxomatous mitral valve disease (MMVD) is a chronic cardiac condition that can have serious hemodynamic consequences and therefore requires lifelong monitoring. However, although echocardiography remains the gold standard for diagnosis and staging, its repetition at short intervals to assess therapeutic response can be limited by cost, logistics, and patient tolerance. In this context, biomarkers such as lactate could serve as a complementary tool to reflect clinical status and prognosis. This study aimed to evaluate the clinical utility of point-of-care (POC) whole blood lactate measurement in dogs with MMVD, with a particular focus on its ability to reflect clinical status within American College of Veterinary Internal Medicine (ACVIM) stages B2 and C.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n This retrospective observational study included 33 client-owned dogs with MMVD examined between June 2025 and November 2025. The population had a mean age of 13.6 years and mean body weight of 4.3 kg. Dogs were classified according to ACVIM stage and clinical status at presentation into three groups: Stage B2 (\n n<\/jats:italic>\n =13), Stage C with controlled congestive heart failure (CHF) (\n n<\/jats:italic>\n =13), and Stage C with acute decompensated CHF (\n n<\/jats:italic>\n =7). Whole blood lactate concentrations were measured using a portable lactate meter (StatStrip Xpress\n \u00ae<\/jats:sup>\n ) via paw pad capillary sampling within approximately 5-minute of acclimatization.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Whole blood lactate concentrations differed significantly among the three groups (\n P<\/jats:italic>\n = 0.002). The Stage C with acute decompensation CHF group exhibited a markedly higher mean lactate concentration (5.61 \u00b1 1.98 mmol\/L) compared to the Stage B2 (2.17 \u00b1 0.95 mmol\/L) and Stage C with controlled CHF (2.50 \u00b1 1.04 mmol\/L) group (\n P<\/jats:italic>\n = 0.002). In contrast, no significant difference was observed between the Stage B2 and Stage C with controlled CHF groups (\n P<\/jats:italic>\n = 0.456). In receiver operating characteristic (ROC) analysis for distinguishing dogs with hemodynamic instability, the area under the curve (AUC) was 0.94 (95% CI: 0.85\u20131.00,\n P<\/jats:italic>\n &lt; 0.001). At a cut-off value of 3.0 mmol\/L, the assay demonstrated 100% sensitivity, 72% specificity, and a 100% negative predictive value (NPV). Lactate concentrations \u2265 3.0 mmol\/L were observed in 2 of 13 dogs (15.4%) in the Stage B2 group, 3 of 13 dogs (23.1%) in the Stage C with controlled CHF group, and 7 of 7 dogs (100%) in the Stage C with acute decompensated CHF group.\n <\/jats:p>\n <\/jats:sec>\n \n Discussion<\/jats:title>\n POC whole blood lactate measurement can serve as a valuable adjunctive screening tool for assessing clinical management status and acute hemodynamic condition in dogs with MMVD. However, lactate values approximating the identified cut-off of 3.0 mmol\/L should not be interpreted as a binary decision threshold. Instead, values in this range indicate a zone of increased clinical uncertainty, warranting closer monitoring and hemodynamic reassessment in conjunction with standard clinical evaluation.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fvets.2026.1759873","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:21:28Z","timestamp":1771564888000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical utility of point-of-care lactate measurement for assessing management status and prognosis in dogs with myxomatous mitral valve disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Wangyu","family":"Choi","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, Jeju National University","place":["Jeju-si, Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-young","family":"Ha","sequence":"additional","affiliation":[{"name":"Jamsil Best Animal Medical Center","place":["Seoul, Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eon-Seung","family":"Jeong","sequence":"additional","affiliation":[{"name":"SEEU Animal Medical Center","place":["Seoul, Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Min","family":"Yun","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Jeju National University","place":["Jeju-si, Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jvc.2012.02.001","article-title":"Pathology of myxomatous mitral valve disease in the dog","volume":"14","author":"Fox","year":"2012","journal-title":"J Vet Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jvc.2012.01.011","article-title":"Historical review, epidemiology and natural history of degenerative mitral valve disease","volume":"14","author":"Borgarelli","year":"2012","journal-title":"J Vet Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/jvim.15488","article-title":"ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs","volume":"33","author":"Keene","year":"2019","journal-title":"J Vet Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/jvim.14586","article-title":"Effect of pimobendan in dogs with preclinical myxomatous mitral valve disease and cardiomegaly: the EPIC study-a randomized clinical trial","volume":"30","author":"Boswood","year":"2016","journal-title":"J Vet Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cll.2015.05.005","article-title":"Using cardiac biomarkers in veterinary practice","volume":"35","author":"Oyama","year":"2015","journal-title":"Clin Lab Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1939-1676.2012.00894.x","article-title":"The impact of confounding factors on NT-proBNP concentrations in dogs with myxomatous mitral valve disease","volume":"26","author":"Hezzell","year":"2012","journal-title":"J Vet Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/jvim.17056","article-title":"Utility of focused cardiac ultrasonography training in differentiating stages of subclinical myxomatous mitral valve disease in dogs","volume":"38","author":"Huh","year":"2024","journal-title":"J Vet Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jvc.2022.01.001","article-title":"Caudal vena cava point-of-care ultrasound in dogs with degenerative mitral valve disease without clinically important right heart disease","volume":"41","author":"Giraud","year":"2022","journal-title":"J Vet Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.rvsc.2006.09.003","article-title":"The \u201cwhite-coat effect\u201d in pet dogs\u2014a comparison between ambulatory and clinic blood pressure measurements","volume":"83","author":"Bodey","year":"2007","journal-title":"Res Vet Sci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"738898","DOI":"10.3389\/fvets.2021.738898","article-title":"Plasmatic dimethylarginines in dogs with myxomatous mitral valve disease","volume":"8","author":"Valente","year":"2021","journal-title":"Front Vet Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1939-1676.2004.tb02629.x","article-title":"Cardiac troponin-I concentration in dogs with cardiac disease","volume":"18","author":"Oyama","year":"2004","journal-title":"J Vet Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1939-165X.2007.tb00217.x","article-title":"Serial blood lactate concentrations in systemically ill dogs","volume":"36","author":"Stevenson","year":"2007","journal-title":"Vet Clin Pathol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1053\/j.tcam.2014.09.005","article-title":"Plasma lactate concentration as a prognostic biomarker in dogs with gastric dilation and volvulus","volume":"29","author":"Mooney","year":"2014","journal-title":"Top Companion Anim Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1590\/1678-5150-pvb-5169","article-title":"Blood lactate increases with the progression of mitral valve disease in dogs","volume":"38","author":"Silva-Filho","year":"2018","journal-title":"Pesq Vet Bras"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.3389\/fvets.2021.789137","article-title":"Assessment of right ventricular function, blood lactate levels, and serum peptidomics profiles associated with mitral valve disease in dogs","volume":"8","author":"Petchdee","year":"2022","journal-title":"Vet World"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/j.1939-1676.2008.0150.x","article-title":"Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by myxomatous mitral valve disease","volume":"22","author":"H\u00e4ggstr\u00f6m","year":"2008","journal-title":"J Vet Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jvc.2023.03.001","article-title":"Selected hematological, biochemical, and echocardiographic variables as predictors of survival in canine patients with myxomatous mitral valve disease and congestive heart failure","volume":"46","author":"Brlo\u017enik","year":"2023","journal-title":"J Vet Cardiol"},{"key":"ref18","volume-title":"Small animal internal medicine","author":"Nelson","year":"2019"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1939-165X.2007.tb00179.x","article-title":"Evaluation of a portable lactate analyzer (lactate scout) in dogs","volume":"36","author":"Ferasin","year":"2007","journal-title":"Vet Clin Pathol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1515\/acve-2016-0047","article-title":"Reliability of the lactate scout point-of-care instrument for the measurement of blood lactate concentrations in agility dogs","volume":"66","author":"Beli\u0107","year":"2016","journal-title":"Acta Vet Beogr"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.2460\/javma.230.9.1315","article-title":"Evaluation of four point-of-care meters for rapid determination of blood lactate concentrations in dogs","volume":"230","author":"Acierno","year":"2007","journal-title":"J Am Vet Med Assoc"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5326\/JAAHA-MS-5700","article-title":"Comparison of two portable lactate meters in dogs","volume":"49","author":"Karagiannis","year":"2013","journal-title":"J Am Anim Hosp Assoc"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1172\/JCI115342","article-title":"Sources of carbon for hepatic glycogen synthesis in the conscious dog","volume":"88","author":"Moore","year":"1991","journal-title":"The Journal of clinical investigation"},{"key":"ref24","first-page":"255","article-title":"Reference interval for whole blood lactate concentrations in healthy dogs samples with two portable point-of-care analyzers","volume":"9","author":"Hughes","year":"1999","journal-title":"J Vet Emerg Crit Care"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/vec.12771","article-title":"Assessment of plasma lactate and core\u2013peripheral temperature gradients in dogs with myxomatous mitral valve disease","volume":"28","author":"Soares","year":"2018","journal-title":"Vet Emerg Crit Care San Antonio"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5326\/0430270","article-title":"Lactate in veterinary critical care: pathophysiology and management","volume":"43","author":"Pang","year":"2007","journal-title":"J Am Anim Hosp Assoc"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"892","DOI":"10.2460\/javma.236.8.892","article-title":"Association between outcome and changes in plasma lactate concentration during presurgical treatment in dogs with gastric dilatation-volvulus: 64 cases (2002\u20132008)","volume":"236","author":"Zacher","year":"2010","journal-title":"J Am Vet Med Assoc"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2460\/javma.246.1.100","article-title":"Survival analysis of critically ill dogs with hypotension with or without hyperlactatemia: 67 cases (2006\u20132011)","volume":"246","author":"Ateca","year":"2015","journal-title":"J Am Vet Med Assoc"},{"key":"ref29","first-page":"67","article-title":"Evaluation of plasma lactate concentration and base excess at the time of hospital admission as predictors of gastric necrosis and outcome in dogs with gastric dilatation-volvulus: 78 cases (2004\u20132009)","volume":"23","author":"Beer","year":"2013","journal-title":"J Vet Emerg Crit Care"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/vec.12234","article-title":"Plasma lactate concentrations in septic peritonitis: a retrospective study of 83 dogs (2007\u20132012)","volume":"25","author":"Cortellini","year":"2015","journal-title":"J Vet Emerg Crit Care"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1476-4431.2010.00599.x","article-title":"Evaluation of initial plasma lactate values as a predictor of gastric necrosis and initial and subsequent plasma lactate values as a predictor of survival in dogs with gastric dilatation-volvulus: 84 dogs (2003\u20132007)","volume":"21","author":"Green","year":"2011","journal-title":"J Vet Emerg Crit Care"},{"key":"ref32","first-page":"560","article-title":"Retrospective evaluation of the prognostic utility of plasma lactate concentration in dogs and cats presenting to an emergency room","volume":"32","author":"Saint-Pierre","year":"2022","journal-title":"J Vet Emerg Crit Care (San Antonio)"},{"key":"ref33","first-page":"98","article-title":"Blood lactate concentration and serial lactate measurement as predictors of outcome in critically ill dogs with babesiosis","volume":"14","author":"Nel","year":"2004","journal-title":"J Vet Emerg Crit Care"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cca.2019.04.003","article-title":"Reliability of the point-of care analyzer \u201cStatStrip\u00ae Xpress\u2122\u201d for measurement of fetal blood lactate","volume":"495","author":"Iorizzo","year":"2019","journal-title":"Clin Chim Acta"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1759873\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:21:30Z","timestamp":1771564890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1759873\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":34,"alternative-id":["10.3389\/fvets.2026.1759873"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2026.1759873","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"article-number":"1759873"}}